Fast and Sustained Axonal Growth by BDNF Released from Chitosan Microspheres.

Area of Science:

• Neuroscience
• Biomaterials Science
• Regenerative Medicine

Background:

• Brain-derived neurotrophic factor (BDNF) is crucial for neuronal health, synaptic plasticity, and recovery from central nervous system (CNS) injuries.
• BDNF deficiency is linked to neurodegenerative diseases like Alzheimer's, Parkinson's, and Huntington's.
• Therapeutic use of BDNF is hindered by its short half-life and inefficient delivery.

Purpose of the Study:

• To evaluate the efficacy of chitosan microsphere-encapsulated BDNF as a sustained-release therapeutic agent.
• To assess the impact of encapsulated BDNF on neuritic outgrowth in a neuronal cell model.
• To determine if chitosan encapsulation improves BDNF's therapeutic potential for CNS disorders.

Main Methods:

• Loading BDNF into chitosan microspheres for controlled release.
• Utilizing the PC12 rat pheochromocytoma cell line, which requires neurotrophins for differentiation via neurotrophin receptors (NTRs).
• Quantifying neuritic outgrowth and growth velocity in response to encapsulated BDNF compared to free BDNF.

Main Results:

• BDNF-loaded chitosan microspheres demonstrated significant and sustained promotion of neuritic outgrowth in PC12 cells (p < 0.001).
• The average neuritic outgrowth velocity was three times higher with encapsulated BDNF compared to free BDNF.
• Chitosan encapsulation effectively prevented rapid clearance and prolonged BDNF's biological activity.

Conclusions:

• Slow release of BDNF from chitosan microspheres enhances neurotrophin receptor (NTR) signaling.
• Encapsulated BDNF effectively promotes axonal growth, offering a promising therapeutic strategy for neurodegenerative diseases and CNS lesions.
• Chitosan microspheres represent a viable delivery system to overcome the limitations of free BDNF in clinical applications.